search results for 
Logo

Fresenius is a health care group providing products and services for dialysis, hospitals, and the medical care of patients at home. In addition, Fresenius focuses on hospital operation, as well as on engineering and services for hospitals and other health care facilities. Approximately 170,000 employees have dedicated themselves to the service of health in about 100 countries worldwide.

Fresenius Medical Care

In 2012, Fresenius Medical Care clearly exceeded strong previous year’s sales and EBIT levels. We strengthened our leading position in the global dialysis market through strong organic growth and acquisitions. Once again, we improved the treatment quality for our patients.

Fresenius Kabi

Our business reported strong growth once again in 2012. All regions contributed to this excellent development, in particular the emerging markets and North America. We also completed the acquisition of Fenwal Holdings, Inc., creating a global market leader in transfusion technology.

Fresenius Helios

2012 was an excellent year. We continued to achieve strong organic sales growth and increased our net income significantly. We also substantially raised the EBIT margin in our established hospitals. We continued to successfully integrate Damp Group and the hospitals of Klinikum Duisburg.

Fresenius Vamed

In 2012, we reached new historical record levels in both sales and EBIT. Strong organic sales growth and acquisitions in the reporting year contributed to this excellent development. Order intake and order backlog also increased substantially, providing a solid base for future growth.

TO OUR SHAREHOLDERS

  

FRESENIUS SHARE 2012

  

KEY TOPICS 2012

  

KEY FIGURES COMPARISON

Picture of Fresenius CEO 2012 marked our 100th
anniversary. As a leading
global health care group
we are dedicated to the
advancement of medicine
and human health – values
we have upheld ever since
our founding as a small
pharmacy lab in 1912.

more... 		 

Fresenius Share 2012 was an extremely successful year on the stock markets, despite the ongoing financial and debt crisis. The Fresenius share maintained excellent momentum. Its share price increased steadily and reached a new record level in October.

more... 		 

100 years of Fresenius

In year 1912, Dr. Eduard
Fresenius set the cornerstone
of our business. In the
laboratory of his Frankfurt
pharmacy he started a
small pharmaceutical
company that became
the global health care
group Fresenius.

more...

Successful Acquisitions

In 2012, all business segments posted significant organic sales growth, taking advantage of opportunities created by market consolidation. Fresenius Kabi acquired Fenwal Holdings and now enjoys a leading position worldwide in transfusion technology. Fresenius Helios significantly strengthened its hospital network in Northern Germany with the acquisition of the Damp Group.

more...

Summary of the fiscal year

Consolidated sales increased
by 18% to €19,290 million
and operating income (EBIT)
grew by 20% to €3,075 million.
The EBIT margin increased
to a new record level of 15.9%.
Group net income increased
by 22% to €938 million and
earnings per share by 15%
to €5.42.

more...

Strategy and Goals

Our goal is to build Fresenius
into a leading global provider
of products and therapies
for critically and chronically ill
people. We are concentrating
our business segments on
a few health care areas.
Thanks to this clear focus,
we have developed unique
competencies.

more...

Employees

Well-trained and experienced employees are vitally
important for our Company’s success. It is largely thanks
to their achievements, skills
and commitment that all
our business segments hold leading positions in their markets.

more...

Outlook

With its international
production and sales platform
and its market-oriented
products and services,
the Fresenius Group is
well positioned for
continued growth in the
coming years.

more...
 

Fresenius Key Figures 2012 Use our interactive key
figures comparison.
Here you can compare
individual key figures
and show them as graphs.

more...